Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA is Of Counsel at Health Law Alliance and a registered U.S. Patent Attorney

Frequently Asked Questions

PBM and pharmacy audits are commonplace for providers, who need to decide whether to handle the audit internally or seek outside assistance. HLA provides the following insights and considerations to assist with that important decision.  

PBM Audits May Be Handled Successfully by Pharmacy Staff

Can you and your staff provide an effective response to a PBM audit? Of course you can.  You know your business better than anyone else, so the default assumption is that pharmacy employees can and should prepare an audit response.

However, there are a number of situations in which audit counsel should be used instead of pharmacy staff, or at least involved in guiding the response.

PBM Audit Attorneys Should Be Used if You Have Concerns About the Scope of the Audit

First, it may sound hokey, but you should trust your instincts. If you get a pit in your stomach when certain claims come under audit, you should listen to what your gut is telling you and think carefully about how to respond.

As we have written about previously, an audit can result in severe consequences, including network termination, license revocation, and even criminal prosecution. Obviously, these are worst-case scenarios, but if an audit causes you worry, that feeling is an unmistakable sign that counsel should be involved.

Pharmacy Audit Attorneys Should Be Used If Audit Risk Factors are Present

Second, take into consideration the totality of circumstances around the audit. Ask yourself why the PBM is focused on the particular claims at issue. Presumably the characteristics of the claims will provide some insight into why the PBM selected them for audit.

The presence or absence of such “audit risk factors” should inform the decision whether to seek counsel. For example, has claims volume increased dramatically? Is there a utilization management process in place? Is the medication a high-margin item? Is there a grey-market for the drug? Are compounds involved? Topicals? DAW codes? Coupons? Was the referral from a telehealth provider? Have patients or prescribers complained about solicitation?

HLA use these factors and our experience to calculate the magnitude of audit risk at issue. For example, the federal government routinely prioritizes enforcement around telehealth, and these relationships typically involve higher claims volume. Therefore, if the audit implicates a telehealth referral, even absent other risk factors, it is prudent to retain counsel before proceeding.

PBM Audit Attorneys Should Be Used to Provide “Audit Insulation”

Finally, the most compelling reason for using counsel to respond to a PBM or pharmacy audit is for the “audit insulation” it provides between the auditor and business. For example, ESI and other PBMs often will seek to question the owner, PIC or staff as part of their investigation. This is extremely problematic for many reasons, including:

  • These inquiries often occur without any prior notice or opportunity to prepare, leading to inaccurate and erroneous assumptions;
  • Your statements can be used against you in the future, including in the context of a subsequent government investigation;
  • At the audit stage, it is important to keep all options open and not commit to a factual position until the full context of the audit becomes clear.

Unfortunately, in today's environment, the safest course is to assume the worst-case scenario and act accordingly. In subsequent communications, we will explore an alarming trend involving the prosecution of pharmacists for audit-related conduct. Although such a scenario is unlikely, the point remains that you should be extremely careful in any interaction with a PBM or its investigator. Forewarned is forearmed.

HLA’s Audit Attorneys Can Protect You and Your Business

In sum, although some audits can be handled internally, providers should retain an attorney to defend most audits due to the extra layer of protection that an attorney provides to the business and its personnel. Audit counsel should have the perspective and experience necessary to understand the full scope of the conduct at issue and its potential implications. In addition, a qualified attorney should be able to provide audit solutions, as well as preliminary strategies for defending any downstream issues that arise. Contact us at (800) 345-4125 or via email at info@healthlawalliance.com if you are being audited.

MORE ARTICLES BY CATEGORY

Get a Free Consultation

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

Texas Moves to Rein in Ketamine Therapy—And Other States are Likely Next

The regulatory environment surrounding ketamine therapy is entering a new phase of maturity and enforcement. Recently, the Texas Medical Board published proposed regulations governing ketamine therapy, one of the first comprehensive regulatory frameworks in the country.

Read More >>

California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business

California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.

Read More >>

New Executive Order Signals Faster Psychedelic Drug Approvals--and Closer DEA Scrutiny

On Saturday, April 18, President Trump signed an executive order designed to accelerate federal drug approvals for psychedelic drugs, a move experts are calling a significant win for patient access. But for ketamine providers and practices offering ketamine-assisted psychotherapy (KAP), increased coordination among regulators means increased scrutiny is inevitable. In this article, we break down what this executive order means for the future of regulatory enforcement.

Read More >>

The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care

On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.

Read More >>